Cargando…
Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
Epithelial ovarian cancer has the highest mortality of the gynecological malignancies. High grade serous epithelial ovarian cancer (SEOC) is the most common subtype, with the majority of women presenting with advanced disease where 5-year survival is around 25%. Platinum-based chemotherapy in combin...
Autores principales: | Marsh, Deborah J., Shah, Jaynish S., Cole, Alexander J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053763/ https://www.ncbi.nlm.nih.gov/pubmed/24971229 http://dx.doi.org/10.3389/fonc.2014.00144 |
Ejemplares similares
-
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017) -
The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014) -
Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
por: Xie, Kangzhe, et al.
Publicado: (2022) -
Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer
por: Chen, Chongyang, et al.
Publicado: (2022) -
Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022)